Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sou Yi Chang"'
Publikováno v:
Tzu-Chi Medical Journal, Vol 34, Iss 2, Pp 219-225 (2022)
Objectives: Transarterial chemoembolization (TACE) or sorafenib may prolong survival in patients with unresectable hepatocellular carcinoma (HCC); however, whether their combination prolongs survival than TACE alone remains controversial. We aimed to
Externí odkaz:
https://doaj.org/article/1ba0be0c8cdd4f9388e272df52b2469f
Autor:
Chao-Chuan Wu, Chih-Wei Tseng, Kuo-Chih Tseng, Yen-Chih Chen, Ta-Wei Wu, Sou-Yi Chang, Yao-Jen Chang, You-Chen Chao, Ching-Sheng Hsu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 5, Pp 1249-1258 (2021)
Background/purpose: Radiofrequency ablation (RFA) is increasingly being used instead of surgical resection for the treatment of hepatocellular carcinoma (HCC) tumor measuring ≦2 cm. However, the long-term outcomes of RFA, especially in comparison t
Externí odkaz:
https://doaj.org/article/1fade2d2efcf4697bc7c56908320f6cb
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 11, Pp 1019-1026 (2018)
Background/purpose: Chemotherapy-induced peripheral neuropathy is a common consequence of chemotherapeutic treatments in patients with cancer. This study evaluated the validity and reliability of a Chinese version of the Neuropathic Pain Symptom Inve
Externí odkaz:
https://doaj.org/article/9ab2fb3466034bad89d66024dcc9eaca
Autor:
Yao-Jen Chang, Chao-Chuan Wu, Ching-Sheng Hsu, Kuo-Chih Tseng, Ta-Wei Wu, Yen-Chih Chen, Chih-Wei Tseng, You-Chen Chao, Sou-Yi Chang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 5, Pp 1249-1258 (2021)
Background/purpose Radiofrequency ablation (RFA) is increasingly being used instead of surgical resection for the treatment of hepatocellular carcinoma (HCC) tumor measuring ≦2 cm. However, the long-term outcomes of RFA, especially in comparison to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e173243830e546ab321f98baf4f3608c
http://www.sciencedirect.com/science/article/pii/S0929664620305581
http://www.sciencedirect.com/science/article/pii/S0929664620305581
Publikováno v:
International Immunopharmacology. 112:109223
Immune checkpoint inhibitor therapy is the backbone of numerous combination regimens for improving the therapeutic response of patients with hepatocellular carcinoma (HCC). We aimed to investigate the therapeutic efficacy of nivolumab plus sorafenib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b27929b7eb15754d9457f2d9970c06
https://doi.org/10.1016/j.intimp.2022.109223
https://doi.org/10.1016/j.intimp.2022.109223
Publikováno v:
Cancer Medicine
Chemotherapy‐induced peripheral neuropathy (CIPN) with restriction of daily activity (RDA) was common consequence of oxaliplatin‐based chemotherapy in colorectal cancer patients. CIPN with RDA and negative mood may impact the quality of life (QoL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b7faa3b30c4b871a7484183c687a97
http://europepmc.org/articles/PMC6434336
http://europepmc.org/articles/PMC6434336
Publikováno v:
Tzu Chi Medical Journal. 34:219
Transarterial chemoembolization (TACE) or sorafenib may prolong survival in patients with unresectable hepatocellular carcinoma (HCC); however, whether their combination prolongs survival than TACE alone remains controversial. We aimed to compare the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0265bf0ab35c350a31eaf1d65559964f
https://doi.org/10.4103/tcmj.tcmj_84_21
https://doi.org/10.4103/tcmj.tcmj_84_21
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 11, Pp 1019-1026 (2018)
Background/purpose: Chemotherapy-induced peripheral neuropathy is a common consequence of chemotherapeutic treatments in patients with cancer. This study evaluated the validity and reliability of a Chinese version of the Neuropathic Pain Symptom Inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af95889446eec335c468325421d8399
http://www.sciencedirect.com/science/article/pii/S0929664617302796
http://www.sciencedirect.com/science/article/pii/S0929664617302796
Autor:
Cheng-Wen Hsiao, Chang-Chieh Wu, Ya-Wen Lin, Chih-Chi Kuo, Sou-Yi Chang, Yu-Lueng Shih, Je-Ming Hu, Yu-Ching Chou, Chih-Hsiung Hsu
Publikováno v:
Genes, Chromosomes and Cancer. 57:268-277
Colorectal cancer (CRC) is a common malignancy worldwide. CRC patients in the same stage often present with dramatically different clinical scenarios. Thus, robust prognostic biomarkers are urgently needed to guide therapies and improve treatment out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9922a93ebb77ad051e4516a5f795fdd3
https://doi.org/10.1002/gcc.22529
https://doi.org/10.1002/gcc.22529
Autor:
Yu-Ching Chou, Cheng-Wen Hsiao, Chih-Chi Kuo, Sou-Yi Chang, Yu-lueng Shih, Chih-Hsiung Hsu, Ya-Wen Lin
Publikováno v:
Cancer Research. 78:2575-2575
Background: Colorectal cancer (CRC) is a common malignancy worldwide. CRC patients in the same stage often present with dramatically different clinical scenarios. Thus, robust prognostic biomarkers are urgently needed to guide therapies and improve t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9c547822687ff0bfa389e478368c265
https://doi.org/10.1158/1538-7445.am2018-2575
https://doi.org/10.1158/1538-7445.am2018-2575